H. Brett Schreyer

Papers

1

Total Citations

110

H-Index

1

About

H. Brett Schreyer is a leading figure in bioprocess engineering, whose work has fundamentally advanced high-throughput cell culture technologies for therapeutic protein production. His research centers on the development and validation of micro-bioreactor systems that dramatically accelerate process development for biologics. Schreyer’s seminal 2010 paper, which has garnered over 110 citations, demonstrated the reproducibility and scalability of a novel micro-bioreactor platform for fed-batch CHO cell cultures. This work directly addressed the critical industry bottleneck of limited experimental design space, proving that miniature systems could reliably predict performance in traditional bench-top bioreactors. By enabling hundreds of parallel, controlled experiments, Schreyer’s innovations help reduce the timeline pressures for bringing therapeutic and vaccine candidates to clinic. His contributions have reshaped how the biopharmaceutical industry approaches cell culture optimization, offering a powerful tool for faster, more efficient process development.

Research Focus

Key Achievements

1
H-Index
1
Papers
110
Total Citations
110
Avg Citations/Paper
🏆 Most Cited Paper
Novel micro‐bioreactor high throughput technology for cell culture process development: Reproducibility and scalability assessment of fed‐batch CHO cultures
110 citations · 2010
📈 Most Prolific Year: 2010 (1 Papers)
🤝 Key Collaborators: 8

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago